ASCO 2023 Annual Meeting
Does the route of administration for HER2 targeted therapy affect overall and progression-free survival?
Certain intrinsic molecular subtypes changed after metastasis compared to the primary tumor subtype.
Overall survival was the least favorable when brain metastasis was diagnosed during or after second-line treatment.
According to a novel prognostic model, patients classified as low-risk had better overall survival.
Advertisement
Advertisement
